Promising Advancements in Tenaya Therapeutics’ Cardiac Gene Therapy Justify Buy Rating
Leerink Partners analyst Mani Foroohar has maintained their bullish stance on TNYA stock, giving a Buy rating yesterday.Stay Ahead of the ...